St. George’s University of London:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:St. George's University of London - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3469
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
St. George’s University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider. It offers undergraduate and post graduate courses. The university’s undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthcare practice foundation degree, biomedical science foundation degree, breast imaging foundation degree, healthcare science and medicine MBBS. It provides post graduate courses such as biomedical science MRes, clinical practice MRes, medical imaging, nursing, oncology practice PgCert, physician associate studies postgraduate diploma, physiotherapy MSc and social work PgDip. SGUL conducts research in the field of cardiovascular and cell sciences, infection and immunity and population health. The university partners with other institutions for its research activities. SGUL is headquartered in London, England, the UK.

St. George’s University of London – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
St. George’s University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
St. George’s University of London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
St. George’s University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
St. George’s University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
St. George’s University of London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
St. George’s University of London, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Symcel Sverige Enter into Partneship with TiKa Diagnostics and St. George’s University 10
DNA2.0 Enters Into Research Agreement With St George’s University Of London For Production Of Therapeutic Antibodies 11
Licensing Agreements 12
Orphan Technologies Enters Into Licensing Agreement With St George’s University of London For Erythrocyte Encapsulated Technology 12
St. George’s University of London – Key Competitors 13
St. George’s University of London – Key Employees 14
St. George’s University of London – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
Dec 11, 2017: Experts discover ways to tackle drug resistant parasites that cause the killer disease malaria 16
Nov 10, 2017: New hope for osteoarthritis patients suffering severe pain in hands 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
St. George's University of London, Pharmaceuticals & Healthcare, Key Facts 2
St. George's University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
St. George's University of London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
St. George's University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
St. George's University of London, Deals By Therapy Area, 2012 to YTD 2018 8
St. George's University of London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Symcel Sverige Enter into Partneship with TiKa Diagnostics and St. George’s University 10
DNA2.0 Enters Into Research Agreement With St George's University Of London For Production Of Therapeutic Antibodies 11
Orphan Technologies Enters Into Licensing Agreement With St George's University of London For Erythrocyte Encapsulated Technology 12
St. George's University of London, Key Competitors 13
St. George's University of London, Key Employees 14

List of Figures
St. George's University of London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
St. George's University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
St. George's University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
St. George's University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
St. George's University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
St. George's University of London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
St. George's University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
St. George's University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[St. George’s University of London:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mangalore Chemicals & Fertilizers Ltd (MANGCHEFER):企業の財務・戦略的SWOT分析
    Summary Mangalore Chemicals & Fertilizers Ltd (MCFL), a subsidiary of Zuari Fertilisers and Chemicals Ltd, is a chemical company that manufactures and markets fertilizers, plant nutrition products, and plant protection chemicals. The company offers urea, di-ammonium phosphate, granulated fertilizers …
  • PT Paninvest Tbk:企業の戦略・SWOT・財務情報
    PT Paninvest Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Paninvest Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Global Investment House KPSC (GLOBAL):企業の財務・戦略的SWOT分析
    Global Investment House KPSC (GLOBAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Universities Superannuation Scheme Ltd:企業のM&A・事業提携・投資動向
    Universities Superannuation Scheme Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Universities Superannuation Scheme Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • America’s Car-Mart, Inc. (CRMT):企業の財務・戦略的SWOT分析
    America's Car-Mart, Inc. (CRMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Banco Comercial Portugues S.A:企業のM&A・事業提携・投資動向
    Banco Comercial Portugues S.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Comercial Portugues S.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • SciClone Pharmaceuticals Inc (SCLN)-製薬・医療分野:企業M&A・提携分析
    Summary SciClone Pharmaceuticals Inc (SciClone) develops and commercializes products for the treatment of cancer, cardiovascular disorders and infectious diseases. The company’s lead product, Zadaxin (thymalfasin), an immunostimulatory agent approved for the treatment of hepatitis B virus (HBV), hep …
  • 88 Energy Ltd (88E):石油・ガス:M&Aディール及び事業提携情報
    Summary 88 Energy Ltd (88 Energy), formerly Tangiers Petroleum Ltd, is an exploration and production company that develops oil-rich provinces. The company offers discovery, exploration and development of onshore oil projects. It has oil and gas assets in Morocco and Australia. 88 Energy’s Morocco pr …
  • Sillajen Biotherapeutics (215600):製薬・医療:M&Aディール及び事業提携情報
    Summary Sillajen Biotherapeutics (SillaJen), formerly SillaJen Inc, is a biotechnology company that designs and develops oncolytic immunotherapeutics for the treatment of cancer. The company’s pipeline products comprise Pexa-Vec, an oncolytic immunotherapeutic virus which is in Phase III trial that …
  • Rexel S.A.:企業の戦略・SWOT・財務分析
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Intec Pharma Ltd (NTEC):製薬・医療:M&Aディール及び事業提携情報
    Summary Intec Pharma Ltd (Intec Pharma) is a biopharmaceutical company that offers delivery solutions for drugs. The company’s pipeline products include drug indications for Parkinson’s disease, insomnia and other diseases. Its proprietary gastro retentive formulation, offers a drug delivery solutio …
  • PECO Energy Co:企業の戦略的SWOT分析
    PECO Energy Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • BioPorto AS (BIOPOR):企業の財務・戦略的SWOT分析
    BioPorto AS (BIOPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Standard Insurance Co. Inc.:企業の戦略・SWOT・財務分析
    Standard Insurance Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary Standard Insurance Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Schuler AG:企業の戦略・SWOT・財務情報
    Schuler AG - Strategy, SWOT and Corporate Finance Report Summary Schuler AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • CTD Holdings Inc (CTDH):製薬・医療:M&Aディール及び事業提携情報
    Summary CTD Holdings Inc (CTDH), formerly Cyclodextrin Technologies Development Inc is a biotechnology company that develops, manufactures and distributes cyclodextrins products. The company’s products include aquaplex, trappsol and trappsol cyclo. It provides trappsol cyclo, which is a hydroxypropy …
  • Mercury NZ Limited:企業の戦略・SWOT・財務分析
    Mercury NZ Limited - Strategy, SWOT and Corporate Finance Report Summary Mercury NZ Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Trimedyne Inc:企業の戦略的SWOT分析
    Trimedyne Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • CEZ, AS:発電所・企業SWOT分析
    CEZ, AS - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • Sharp HealthCare:企業の戦略的SWOT分析
    Sharp HealthCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆